Effect of reporting a diagnosis on the behavior of HIV-infected people

Relevance. According to US scientists, the percentage of people who do not know about their positive status is 20% of all people living with HIV. Moreover, this group provides 49% of new infections. Therefore, it can be assumed that information about HIV status has a significant epidemiological effect. Aim. To assess the change in risk behavior of HIV-infected persons after informing about the diagnosis and the frequency of occurrence of nonspecific symptoms of HIV infection. Materials and methods. For information on changing the behavior profile was developed, consisting of three sections. The first and third sections are aimed at elucidating the characteristics of sexual and drug behavior from the moment of probable infection to the moment of diagnosis, in comparison with the time period from the moment of reporting the diagnosis to the present. The second section of questions is aimed at determining the frequency of occurrence of nonspecific symptoms of early HIV infection. In the survey agreed to participate in 79 HIV-infected patients. The reliability of the results obtained was determined using the Wilcoxon Sign Test. Results. The message of the diagnosis of HIV infection contributed to the desire to abandon the systematic use of intravenous drugs. The proportion of people who denied drug use increased from 13 to 65% (p < 0.05). The number of people infected intensively (30 and more doses / month) using drugs has more than halved – from 38 to 17% (p < 0.05). The number of people denying drug use in groups increased from 10 to 45% (p < 0.05). From 55 to 12% (p < 0.05), the proportion of people who pass their syringe (needle) to another person to inject drugs has decreased. The number of persons who noted the presence of more than 5 partners per year after diagnosis decreased three times (p < 0.05). Only 23% of the respondents did not present any complaints in the period preceding the detection of HIV infection. Symptoms of acute respiratory disease marked 48%, 37% had fever, and other non-specific clinical manifestations of HIV infection. Conclusion. Communicating a positive HIV status to a patient reduces the likelihood of HIV transmission by drugs by 3–4 times and sexually by 2–3 times by changing risky behavior. Nonspecific symptoms of an acute viral disease before the detection of HIV infection were recorded in 48% of cases.

1. Hall H. I.; Holtgrave D. R., Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893–896. doi: 10.1097/QAD.0b013e328351f73f.

2. Skarbinski J., Rosenberg E., Paz-Bailey G., et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Internal Medicine. 2015;175(4):588–596. doi: 10.1001/jamainternmed.2014.8180.

3. GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10152):1015–1035. doi: 10.1016/s0140-6736(18)31310-2.

4. Plavinskii S.L., Ladnaya N.N., Zaytseva E.E., et al. Harmful and hazardous alcohol consumption among individuals with high risk of HIV infection. Russian Family Doctor. 2018;22(4):37–48. (In Russ). doi: 10.17816/RFD2018437-48.

5. Yakovlev A.A., Chaika N.A., Kelly J., et al. Alcohol abuse and HIV infection. HIV Infection and Immunosuppressive Disorders. 2017;9(4):17–32. (In Russ). doi: 10.22328/2077-9828-2017-9-4-17-32.

6. Rampaul M., Edun B., Gaskin M., et al. Cost-effectiveness analysis of early vs late diagnosis of HIV-infected patients in South Carolina. Southern Medical Journal. 2018;111(6):355–358. doi: 10.14423/SMJ.0000000000000819.

7. Lisitsyna Z.N., Krutitskaya L.I., Dementjeva N.Ye., et al. Standards of laboratory tests for HIV and the cost of HIV detection and monitoring. HIV Infection and Immunosuppressive Disorders. 2010;2(4):79–85 (In Russ).

8. Berta А., Gualano M.R., Biancone P., et al. Cost-effectiveness of HIV screening in high-income countries: a systematic review. Health Policy. 2018;122(5):533–547. doi: 10.1016/j.healthpol.2018.03.007.

9. Kasaie P., Radford M., Kapoor S., et al. Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain. PLoS ONE. 2018;13(11): e0206755. doi: 10.1371/journal.pone.0206755.

10. Toussova O.V., Blokhina E.A., Grinenko A.Y., et al. A randomized controlled trial to reduce sexually transmitted infections and HIV-risk behaviors among HIV-infected russian drinkers. Voprosy narkologii. 2017;12(160):23–43 (In Russ).

11. Salamov G.G., Bobkova M.R., Tavasieva V.E., et al. Counseling as a way to enhance adherence of HIV-positive patients. Infect Dis. 2012;10(3):75–79 (In Russ).

12. Hanson D.L., Song R., Masciotra S., et al. Mean recency period for estimation of HIV-1 incidence with the BED-Capture EIA and BioRad avidity in persons diagnosed in the United States with subtype B. PLoS ONE. 2016;11(4): e0152327. doi: 10.1371/journal.pone.0152327.

13. Zagryadskaya Y.E., Neshumaev D. A., Kokotyuha Y.A., et al. Assesment of a new assay «DS-EIA-HIV-AB-TERM» to determine the probable term of infection with human immunodeficiency virus-1 (HIV-1). Epidemiologiya i Infektsionnye Bolezni. 2015;20(3):23–27(In Russ).

14. Neshumaev D.A., Malysheva M.A., Shevchenko N.M., et al. Modeling the dynamics of the HIV epidemic with the use of frequency of early infections. HIV Infection and Immunosuppressive Disorders. 2016;8(2):53–60 (In Russ). doi: 10.22328/2077-9828-2016-8-2-53-60.

15. Rosenberg N.E., Pilcher C.D., Busch M.P., et al. How can we better identify early HIV infections? Current Opinion in HIV and AIDS. 2015;10(1):61–68. doi: 10.1097/ COH.0000000000000121.

16. Hoenig M., Green N., Camacho M., et al. Signs or symptoms of acute HIV infection in a cohort undergoing community-based screening. Emerging Infectious Diseases. 2016;22(3):532–534. doi: 10.3201/eid2203.151607.

17. Haukoos J.S., Hopkins E., Bender B., et al. Comparison of enhanced targeted rapid HIV screening using the Denver HIV risk score to nontargeted rapid HIV screening in the emergency department. Annals of Emergency Medicine. 2013;61(3):353–361. doi: 10.1016/j.annemergmed.2012.10.031.

18. Krasnoselskikh T.V., Shaboltas A.V. Multidisciplinary approach to the prevention of sexually transmitted infections and blood-borne infections. HIV Infection and Immunosuppressive Disorders. 2018;10(4):100–112 (In Russ). doi: 10.22328/2077-9828-2018-10-4-100-112.

19. Shaboltas A.V., Rybnikov V.Yu., Granovskaya R.M., et al. Basic principles and components of effective psychological HIV prevention technologies. HIV Infection and Immunosuppressive Disorders. 2018;10(1):92–102 (In Russ). doi: 10.22328/2077-9828-2018-10-1-92-102.